| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | SRCR | 6.31e-07 | 21 | 62 | 4 | PF00530 | |
| Domain | SR | 1.32e-06 | 25 | 62 | 4 | SM00202 | |
| Domain | - | 1.32e-06 | 25 | 62 | 4 | 3.10.250.10 | |
| Domain | SRCR_1 | 1.56e-06 | 26 | 62 | 4 | PS00420 | |
| Domain | SRCR_2 | 1.56e-06 | 26 | 62 | 4 | PS50287 | |
| Domain | SRCR-like_dom | 1.56e-06 | 26 | 62 | 4 | IPR017448 | |
| Domain | SRCR | 1.82e-06 | 27 | 62 | 4 | IPR001190 | |
| Domain | Tgfb1i1/Leupaxin | 1.08e-05 | 2 | 62 | 2 | IPR017305 | |
| Domain | LLGL | 6.48e-05 | 4 | 62 | 2 | PF08366 | |
| Domain | Lethal2_giant | 6.48e-05 | 4 | 62 | 2 | IPR000664 | |
| Domain | LLGL2 | 6.48e-05 | 4 | 62 | 2 | IPR013577 | |
| Domain | WD40 | 2.59e-04 | 268 | 62 | 6 | SM00320 | |
| Domain | WD40_repeat | 2.80e-04 | 272 | 62 | 6 | IPR001680 | |
| Domain | WD_REPEATS_1 | 3.15e-04 | 278 | 62 | 6 | PS00678 | |
| Domain | WD_REPEATS_2 | 3.21e-04 | 279 | 62 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.21e-04 | 279 | 62 | 6 | PS50294 | |
| Domain | WD40_repeat_dom | 4.48e-04 | 297 | 62 | 6 | IPR017986 | |
| Domain | CUB | 5.76e-04 | 49 | 62 | 3 | PF00431 | |
| Domain | CUB | 6.11e-04 | 50 | 62 | 3 | SM00042 | |
| Domain | - | 6.86e-04 | 52 | 62 | 3 | 2.60.120.290 | |
| Domain | CUB | 7.25e-04 | 53 | 62 | 3 | PS01180 | |
| Domain | - | 8.15e-04 | 333 | 62 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 8.41e-04 | 335 | 62 | 6 | IPR015943 | |
| Domain | CUB_dom | 8.97e-04 | 57 | 62 | 3 | IPR000859 | |
| Domain | LIM | 1.56e-03 | 69 | 62 | 3 | PF00412 | |
| Domain | - | 1.63e-03 | 70 | 62 | 3 | 2.10.110.10 | |
| Domain | WD40 | 1.68e-03 | 259 | 62 | 5 | PF00400 | |
| Domain | Znf_LIM | 1.70e-03 | 71 | 62 | 3 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 1.70e-03 | 71 | 62 | 3 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 1.70e-03 | 71 | 62 | 3 | PS50023 | |
| Domain | LIM | 1.70e-03 | 71 | 62 | 3 | SM00132 | |
| Domain | VWFC_1 | 6.35e-03 | 36 | 62 | 2 | PS01208 | |
| Domain | VWC | 7.06e-03 | 38 | 62 | 2 | SM00214 | |
| Domain | VWFC_2 | 7.06e-03 | 38 | 62 | 2 | PS50184 | |
| Domain | VWF_dom | 8.57e-03 | 42 | 62 | 2 | IPR001007 | |
| Pubmed | GIT1 utilizes a focal adhesion targeting-homology domain to bind paxillin. | 5.65e-08 | 5 | 63 | 3 | 17467235 | |
| Pubmed | Binding of paxillin to alpha4 integrins modifies integrin-dependent biological responses. | 1.13e-07 | 6 | 63 | 3 | 10604475 | |
| Pubmed | 4.72e-07 | 9 | 63 | 3 | 28935710 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 22112519 | ||
| Pubmed | Paxillin family of focal adhesion adaptor proteins and regulation of cancer cell invasion. | 3.23e-06 | 2 | 63 | 2 | 32859368 | |
| Pubmed | Roles of paxillin family members in adhesion and ECM degradation coupling at invadosomes. | 3.23e-06 | 2 | 63 | 2 | 27269065 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 25231004 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 21148292 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 20473281 | ||
| Pubmed | Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells. | 3.23e-06 | 2 | 63 | 2 | 27105023 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 19917054 | ||
| Pubmed | A kindlin-3-leupaxin-paxillin signaling pathway regulates podosome stability. | 9.68e-06 | 3 | 63 | 2 | 31537712 | |
| Pubmed | PU.1 binds to a distal regulatory element that is necessary for B cell-specific expression of CIITA. | 9.68e-06 | 3 | 63 | 2 | 20363966 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 38159847 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 11784865 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 38165930 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 17233630 | ||
| Pubmed | Interaction of Hic-5, A senescence-related protein, with focal adhesion kinase. | 9.68e-06 | 3 | 63 | 2 | 9756887 | |
| Pubmed | Paxillin and Hic-5 interaction with vinculin is differentially regulated by Rac1 and RhoA. | 1.93e-05 | 4 | 63 | 2 | 22629471 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 15242870 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 16261165 | ||
| Pubmed | ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis. | 1.93e-05 | 4 | 63 | 2 | 25193384 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 11463817 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 34537235 | ||
| Pubmed | Hic-5 interacts with GIT1 with a different binding mode from paxillin. | 1.93e-05 | 4 | 63 | 2 | 12153727 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 21216962 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 11805099 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 9422762 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 25742295 | ||
| Pubmed | FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages. | 1.93e-05 | 4 | 63 | 2 | 29238041 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 20972335 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 21518930 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 24612059 | ||
| Pubmed | HIF1α and HIF2α independently activate SRC to promote melanoma metastases. | 3.22e-05 | 5 | 63 | 2 | 23563312 | |
| Pubmed | Cathepsin E: a novel target for regulation by class II transactivator. | 3.22e-05 | 5 | 63 | 2 | 15100295 | |
| Pubmed | Differential recruitment of E3 ubiquitin ligase complexes regulates RET isoform internalization. | 3.22e-05 | 5 | 63 | 2 | 28794017 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 23607312 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 10479448 | ||
| Pubmed | 3.28e-05 | 201 | 63 | 5 | 25192599 | ||
| Pubmed | 4.05e-05 | 210 | 63 | 5 | 16537572 | ||
| Pubmed | CRL4-DDB1-VPRBP ubiquitin ligase mediates the stress triggered proteolysis of Mcm10. | 4.82e-05 | 6 | 63 | 2 | 22570418 | |
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 28002729 | ||
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 24429361 | ||
| Pubmed | Role of the NEDD8 modification of Cul2 in the sequential activation of ECV complex. | 6.74e-05 | 7 | 63 | 2 | 17132228 | |
| Pubmed | PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells. | 6.74e-05 | 7 | 63 | 2 | 10648399 | |
| Pubmed | UBXN7 docks on neddylated cullin complexes using its UIM motif and causes HIF1α accumulation. | 6.74e-05 | 7 | 63 | 2 | 22537386 | |
| Pubmed | SPOP inhibits BRAF-dependent tumorigenesis through promoting non-degradative ubiquitination of BRAF. | 8.98e-05 | 8 | 63 | 2 | 36585710 | |
| Pubmed | DCNL1 functions as a substrate sensor and activator of cullin 2-RING ligase. | 1.15e-04 | 9 | 63 | 2 | 23401859 | |
| Pubmed | 1.15e-04 | 9 | 63 | 2 | 10330411 | ||
| Pubmed | Essential role of B-Raf in ERK activation during extraembryonic development. | 1.44e-04 | 10 | 63 | 2 | 16432225 | |
| Pubmed | 1.44e-04 | 10 | 63 | 2 | 9632636 | ||
| Pubmed | Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1. | 1.44e-04 | 10 | 63 | 2 | 25974097 | |
| Pubmed | 1.44e-04 | 10 | 63 | 2 | 21840486 | ||
| Pubmed | 1.76e-04 | 11 | 63 | 2 | 25147341 | ||
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 25505247 | ||
| Pubmed | KRAS or BRAF mutations cause hepatic vascular cavernomas treatable with MAP2K-MAPK1 inhibition. | 2.11e-04 | 12 | 63 | 2 | 32405640 | |
| Pubmed | The human plasma proteome: a nonredundant list developed by combination of four separate sources. | 2.34e-04 | 165 | 63 | 4 | 14718574 | |
| Pubmed | 2.61e-04 | 68 | 63 | 3 | 14676191 | ||
| Pubmed | A trans-eQTL network regulates osteoclast multinucleation and bone mass. | 2.90e-04 | 14 | 63 | 2 | 32553114 | |
| Pubmed | Identification of novel human WW domain-containing proteins by cloning of ligand targets. | 4.85e-04 | 18 | 63 | 2 | 9169421 | |
| Pubmed | 5.69e-04 | 371 | 63 | 5 | 25241761 | ||
| Pubmed | Lack of Flvcr2 impairs brain angiogenesis without affecting the blood-brain barrier. | 7.29e-04 | 22 | 63 | 2 | 32369453 | |
| Pubmed | 7.29e-04 | 22 | 63 | 2 | 26631746 | ||
| Pubmed | 7.29e-04 | 22 | 63 | 2 | 27521426 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 8.44e-04 | 232 | 63 | 4 | 25515538 | |
| Pubmed | Reconstitution of human CMG helicase ubiquitylation by CUL2LRR1 and multiple E2 enzymes. | 8.69e-04 | 24 | 63 | 2 | 34195792 | |
| Pubmed | 1.18e-03 | 28 | 63 | 2 | 18839057 | ||
| Pubmed | 1.27e-03 | 29 | 63 | 2 | 21998595 | ||
| Pubmed | 1.34e-03 | 263 | 63 | 4 | 20932939 | ||
| Pubmed | Regulation of ETAA1-mediated ATR activation couples DNA replication fidelity and genome stability. | 1.43e-03 | 122 | 63 | 3 | 31615875 | |
| Pubmed | 1.55e-03 | 32 | 63 | 2 | 9611252 | ||
| Pubmed | 1.75e-03 | 34 | 63 | 2 | 15604097 | ||
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 4.61e-05 | 27 | 47 | 3 | 1253 | |
| GeneFamily | WD repeat domain containing | 5.71e-05 | 262 | 47 | 6 | 362 | |
| GeneFamily | LIM domain containing | 4.83e-04 | 59 | 47 | 3 | 1218 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_UP | 8.42e-06 | 199 | 63 | 6 | M4945 | |
| Coexpression | GSE29618_PDC_VS_MDC_DN | 8.66e-06 | 200 | 63 | 6 | M4952 | |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN | 1.02e-04 | 193 | 63 | 5 | M4723 | |
| Coexpression | GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.07e-04 | 195 | 63 | 5 | M5334 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN | 1.10e-04 | 196 | 63 | 5 | M3448 | |
| Coexpression | GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP | 1.15e-04 | 198 | 63 | 5 | M8370 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN | 1.18e-04 | 199 | 63 | 5 | M8044 | |
| Coexpression | GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 1.18e-04 | 199 | 63 | 5 | M4460 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 1.18e-04 | 199 | 63 | 5 | M9124 | |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP | 1.21e-04 | 200 | 63 | 5 | M318 | |
| Coexpression | GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP | 1.21e-04 | 200 | 63 | 5 | M7991 | |
| Coexpression | GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP | 1.21e-04 | 200 | 63 | 5 | M7283 | |
| Coexpression | GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_DN | 1.21e-04 | 200 | 63 | 5 | M7155 | |
| Coexpression | GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP | 1.21e-04 | 200 | 63 | 5 | M8532 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN | 1.21e-04 | 200 | 63 | 5 | M4486 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | 1.53e-04 | 646 | 63 | 8 | M2419 | |
| ToppCell | mild_COVID-19-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.25e-08 | 197 | 63 | 7 | 5d826f4d7b7a46847c67e6bef38eb860bc808a6c | |
| ToppCell | mild_COVID-19_(asymptomatic)-Classical_Monocyte|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.34e-08 | 199 | 63 | 7 | 73a98d19871ffbc3c631de330998d42e9afa6da2 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.46e-08 | 157 | 63 | 6 | ed387cf06d19e201a2a0dc4f3c796fcf8fa6637a | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.05e-07 | 179 | 63 | 6 | 99894067e2c2a3ed53abdc5434410c3172693496 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-07 | 180 | 63 | 6 | cc31d2cd06161300b91b17a67bb432b75f0d719b | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-07 | 182 | 63 | 6 | 94d061b7b5ebbfc564c644bc8b2d52341927145d | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.29e-07 | 194 | 63 | 6 | 3043f6230fa723037c8cf7123f611ae847b39fd4 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.29e-07 | 194 | 63 | 6 | 5a048bd2af30975fdc57ff40bc49aa5811c830d8 | |
| ToppCell | mild_COVID-19-Classical_Monocyte|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.71e-07 | 198 | 63 | 6 | 5b31b6e008e05d6528656114fbe0ccae8ffe13b1 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.82e-07 | 199 | 63 | 6 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Classical_monocytes|bone_marrow / Manually curated celltypes from each tissue | 3.82e-07 | 199 | 63 | 6 | 2c747e9265594e12d46bd8c8de75c45e83144155 | |
| ToppCell | severe-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.94e-07 | 200 | 63 | 6 | db7046741706376682d164c385c4701aebefc2e6 | |
| ToppCell | severe-Classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.94e-07 | 200 | 63 | 6 | f46689940fdea500ce2457eec412dd2c46705819 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-06 | 148 | 63 | 5 | 31a7c2b20970070b14d2b955020320a6f99db547 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.47e-06 | 152 | 63 | 5 | 27718e92715ddc80f28b457a5d6d6a3ac2b205d2 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.90e-06 | 157 | 63 | 5 | e9d0300361b06aec3c216f8af15f09e14b12a4da | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.99e-06 | 158 | 63 | 5 | e9657d8960d499832f9f9b45b5a6f4388551b7e1 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-06 | 160 | 63 | 5 | 5c28121916a12dbc22ef2421040bdc9148a40b78 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-06 | 160 | 63 | 5 | b7093678987575f2f99d648821d31b4a37075aca | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.69e-06 | 165 | 63 | 5 | 1c630f9ecde2e0243922a2be4b1ab5adcfcb0893 | |
| ToppCell | (0)_Myeloid-(00)_Monocyte-(000)_CD14+_Monocyte|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization) | 3.92e-06 | 167 | 63 | 5 | 7d9fd6a7a45c2aa0d5f2e3960ca4c97ee8836ba5 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-06 | 167 | 63 | 5 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.27e-06 | 170 | 63 | 5 | 138235227fc4c3d660c3a06e8e5167bf64f076b3 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-pre-pDC/DC5|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.96e-06 | 182 | 63 | 5 | 748401d2c84260a777001dd75b0182453185addc | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.28e-06 | 184 | 63 | 5 | 8e5fc2bdd3071e782aa8c56b8a39f8ea8f03f623 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.34e-06 | 190 | 63 | 5 | e5625feb21915d4545cfad2659745ef180efcb1f | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.34e-06 | 190 | 63 | 5 | 912aa106581d1ed7e147c92f9a367e8e6b04052b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-06 | 190 | 63 | 5 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 7.53e-06 | 191 | 63 | 5 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.53e-06 | 191 | 63 | 5 | d4f77c73311d1149466bbfe4adbd6a301946ec90 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.53e-06 | 191 | 63 | 5 | bce138f067b8962ecef1ddec6511a3f142d81d78 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.72e-06 | 192 | 63 | 5 | f14ee74ac3275601749a23c5efe39c2413a62e1a | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.72e-06 | 192 | 63 | 5 | 8b4bbbadeac70f65378697120c754f10501b5651 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.72e-06 | 192 | 63 | 5 | 4e3deefd30adb7bf1eba294610eed3d077aa9418 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.72e-06 | 192 | 63 | 5 | 0219093e7921a0db78053aee13ec480b520f5662 | |
| ToppCell | ILEUM-inflamed-(3)_moDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.12e-06 | 194 | 63 | 5 | c9d2acab0bbcfa9a9113cf3b9f8147403f0beb43 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.33e-06 | 195 | 63 | 5 | 0110b976f98561ecd2e20ff6e7e3960a401bb7c2 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.33e-06 | 195 | 63 | 5 | f289a44010788853d7726d4b5aa75f3c62186c08 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.33e-06 | 195 | 63 | 5 | 050fc59b328391d6e3ce23051764a842dcbb3144 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-06 | 195 | 63 | 5 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | myeloid-CD14+_Monocyte|World / Lineage and Cell class | 8.54e-06 | 196 | 63 | 5 | b70f9402a1707671c0dd44226fa2adfc4bde8283 | |
| ToppCell | ILEUM-non-inflamed-(3)_moDC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.54e-06 | 196 | 63 | 5 | e10f01172fd076d6892906853f9375d4c3058951 | |
| ToppCell | mild_COVID-19_(asymptomatic)|World / disease group, cell group and cell class (v2) | 8.54e-06 | 196 | 63 | 5 | 8cb3dcb3e5732f4bb060c87ca339b8997a1a8cd4 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.54e-06 | 196 | 63 | 5 | fa24d7c4b7c65e98b209db302a16c58ceac1a105 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Non-resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.75e-06 | 197 | 63 | 5 | 774a5053f43ac7d614c127ae7363d32a3a194f63 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.75e-06 | 197 | 63 | 5 | e698a0bbb20bd4868ff4348f2ac9f609942b55fa | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.75e-06 | 197 | 63 | 5 | d95565652ca318a2298d6918d54ba6367e9560f4 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.75e-06 | 197 | 63 | 5 | 6e96a6c2576f52b72aeab1e41f47a0af05ff327a | |
| ToppCell | Monocytes-cDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.75e-06 | 197 | 63 | 5 | 3388c104af4c6a05988e102627e0c5e34d9dcc45 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.75e-06 | 197 | 63 | 5 | a80be1081f3ed0aceea69a33be21bca6bc354472 | |
| ToppCell | background-Kupffer_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 8.75e-06 | 197 | 63 | 5 | 8b45c7ecc18d188abc8c172d9bf881c95617a46a | |
| ToppCell | COVID-19_Moderate-Classical_Monocyte|World / disease group, cell group and cell class | 8.75e-06 | 197 | 63 | 5 | 16cf3939e700aef1e16159f0652ba2dfad287e7a | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.97e-06 | 198 | 63 | 5 | cf0fda1a24449cfd8ed56ffc7841d8accb187949 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.97e-06 | 198 | 63 | 5 | d347462ba6cb1c5a59c86dffbbe914cbc1e9cf16 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.97e-06 | 198 | 63 | 5 | 96883ad8e189a46ed5b7eaafc0543e53682d26ed | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.97e-06 | 198 | 63 | 5 | c5a22846bccff948f90bc1d5fe309907dcd08348 | |
| ToppCell | COVID-19_Mild-Myeloid-Classical_Monocyte|COVID-19_Mild / Disease group, lineage and cell class | 8.97e-06 | 198 | 63 | 5 | e78d027a095473af555762a4d542a73f5bb2e166 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.97e-06 | 198 | 63 | 5 | 06201b34d3e38f22c93b759511f7b376504bac06 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.97e-06 | 198 | 63 | 5 | 7e1f08dae11a7cc7949a5622d82c7e6660d06dea | |
| ToppCell | PBMC-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.97e-06 | 198 | 63 | 5 | a8338da2477ccf8e3d924de8dbe1056b98111532 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.97e-06 | 198 | 63 | 5 | 525adc91fd8f2ad957b1879a5bf3950baa7d5ef8 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.97e-06 | 198 | 63 | 5 | c49c71b34151d82b8795763bcb633c301c35f659 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.97e-06 | 198 | 63 | 5 | 79c8ab15e73f727c5e110ab9eab3ccb5edf9f714 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.97e-06 | 198 | 63 | 5 | 88635244a0b306d2cc50b8412fe47bb359c9cf00 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.97e-06 | 198 | 63 | 5 | 70e62d815b2a0aa5327ff94d6f4d503176e007b9 | |
| ToppCell | COVID-19_Severe-Myeloid-Classical_Monocyte|COVID-19_Severe / Disease group, lineage and cell class | 8.97e-06 | 198 | 63 | 5 | dfe92577c7d1e63315c7564d5d99362c6e7d4d46 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.97e-06 | 198 | 63 | 5 | 0128d00e6c3f99a026329dd169c0ea5e0e24c59c | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.97e-06 | 198 | 63 | 5 | 4780f0276546962a2fc9f1041cfe49d2919d72b2 | |
| ToppCell | severe_COVID-19-Classical_Monocyte|severe_COVID-19 / disease group, cell group and cell class (v2) | 8.97e-06 | 198 | 63 | 5 | 40dd3333945aa0c9120296b75155c621f462dbe8 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.97e-06 | 198 | 63 | 5 | be038619157aeaa7a57ebd66392de940df4f8127 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.97e-06 | 198 | 63 | 5 | 51c220507bb05aa6338fec494b8ecf4902437708 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 8.97e-06 | 198 | 63 | 5 | b88c4c0ed1abf0a28dbe05b04b9bee1073855ba8 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.97e-06 | 198 | 63 | 5 | 1ca91559fef231896e16180f5e050155c38f7cfa | |
| ToppCell | PBMC-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.97e-06 | 198 | 63 | 5 | 603846129560d5d6e6df27d6168f67f592e5e6e2 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 8.97e-06 | 198 | 63 | 5 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | PBMC-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.19e-06 | 199 | 63 | 5 | 02256d86541be6851634283047fdc05fdf095114 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 199 | 63 | 5 | 04adf46975aa4194ea40c7480f8a517def5d929c | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.19e-06 | 199 | 63 | 5 | 9314eb9a89407738626a0384884454b5f9031ee7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.19e-06 | 199 | 63 | 5 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | control-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.19e-06 | 199 | 63 | 5 | 31825ba336603fe940dea6022e18ec25af110f4c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 199 | 63 | 5 | e1066e638af83ba5e89c7cabb8ad00b6bcdee5f4 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic|bone_marrow / Manually curated celltypes from each tissue | 9.19e-06 | 199 | 63 | 5 | 62b0861faf173eead75678aad10d396cd0d80c2c | |
| ToppCell | Healthy/Control-Classical_Monocyte|World / Disease group and Cell class | 9.19e-06 | 199 | 63 | 5 | 527c767a09f911e319f7ad230b6518cebc0f367d | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Monocytic|bone_marrow / Manually curated celltypes from each tissue | 9.19e-06 | 199 | 63 | 5 | 51a766f823a9d50a3b1d59d0df2f5241a6b44c2b | |
| ToppCell | PBMC-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.19e-06 | 199 | 63 | 5 | 27667838e065370d4536eaaf5b42ad322a714b96 | |
| ToppCell | COVID-19_Mild-Myeloid|COVID-19_Mild / Disease group, lineage and cell class | 9.19e-06 | 199 | 63 | 5 | d0c230c3699955a80630b63ed18c770444c5dfe5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 199 | 63 | 5 | ca0f6526ba0dcf8789dd3b583291519626427f2f | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.19e-06 | 199 | 63 | 5 | 7b3d4c62b11268c7c1599600d8a7b331287cf21a | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.19e-06 | 199 | 63 | 5 | a4785c1921a3de18a9190e4d674ede6a90f80004 | |
| ToppCell | Healthy_donor-Classical_Monocyte|Healthy_donor / disease group, cell group and cell class (v2) | 9.19e-06 | 199 | 63 | 5 | af3a80dbf5e0306b80f420fd41f1aaed81fe9c46 | |
| ToppCell | COVID-19_Severe-Myeloid|COVID-19_Severe / Disease group, lineage and cell class | 9.19e-06 | 199 | 63 | 5 | babbf3220cc811a1794032e06c6cec4dfc7bff2f | |
| ToppCell | mild_COVID-19_(asymptomatic)-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 9.19e-06 | 199 | 63 | 5 | 727122b6f4ca265d2826c9271b10a4215a9d45a3 | |
| ToppCell | Healthy/Control-Classical_Monocyte|Healthy/Control / Disease group and Cell class | 9.19e-06 | 199 | 63 | 5 | 4e8c7445d32fd2b7a50524dcd52141e76850c3df | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.19e-06 | 199 | 63 | 5 | dbf0bf09896c46155ae6fbd6307f097799e7e34e | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Monocytic-Classical_monocytes|bone_marrow / Manually curated celltypes from each tissue | 9.19e-06 | 199 | 63 | 5 | 93f25e8f22deb438c930c2e95e572dbd16503f71 | |
| ToppCell | COVID_vent-Myeloid|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.41e-06 | 200 | 63 | 5 | 621af09aae34226902c03edf556562f3ab35a7d8 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.41e-06 | 200 | 63 | 5 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.41e-06 | 200 | 63 | 5 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| ToppCell | severe-HLA-DR-_S100A+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.41e-06 | 200 | 63 | 5 | a5eb50cbf3e94f0b3aa0fbef888989a11cffea37 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-CD14+_Monocyte|COVID-19_Mild / Disease, condition lineage and cell class | 9.41e-06 | 200 | 63 | 5 | f76d3647f8ab5f7be018b0697c911597198e03f5 | |
| Disease | Melanoma, Cloudman S91 | 8.77e-05 | 7 | 61 | 2 | C0009075 | |
| Disease | Melanoma, Experimental | 8.77e-05 | 7 | 61 | 2 | C0025205 | |
| Disease | Melanoma, B16 | 8.77e-05 | 7 | 61 | 2 | C0004565 | |
| Disease | Melanoma, Harding-Passey | 8.77e-05 | 7 | 61 | 2 | C0018598 | |
| Disease | Non-Small Cell Lung Carcinoma | 3.10e-04 | 156 | 61 | 4 | C0007131 | |
| Disease | squamous cell lung carcinoma, family history of lung cancer | 7.36e-04 | 85 | 61 | 3 | EFO_0000708, EFO_0006953 | |
| Disease | Glioma | 7.87e-04 | 87 | 61 | 3 | C0017638 | |
| Disease | Cerebral Astrocytoma | 1.22e-03 | 25 | 61 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.22e-03 | 25 | 61 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 1.22e-03 | 25 | 61 | 2 | C0334583 | |
| Disease | Astrocytoma | 1.22e-03 | 25 | 61 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.22e-03 | 25 | 61 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.22e-03 | 25 | 61 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 1.22e-03 | 25 | 61 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.22e-03 | 25 | 61 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.22e-03 | 25 | 61 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 1.22e-03 | 25 | 61 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 1.32e-03 | 26 | 61 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.32e-03 | 26 | 61 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.32e-03 | 26 | 61 | 2 | C0334582 | |
| Disease | Anaplastic astrocytoma | 1.43e-03 | 27 | 61 | 2 | C0334579 | |
| Disease | cortical thickness, neuroimaging measurement | 1.55e-03 | 110 | 61 | 3 | EFO_0004346, EFO_0004840 | |
| Disease | Malignant neoplasm of breast | 1.60e-03 | 1074 | 61 | 8 | C0006142 | |
| Disease | neutrophil count | 2.04e-03 | 1382 | 61 | 9 | EFO_0004833 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HSVTASGAEHWREVC | 401 | Q9BT88 | |
| DFESTCWNDGKHHHS | 41 | A8K979 | |
| WCEGSSLYHHLHIIE | 531 | P15056 | |
| ETFAWCRSHSHQGHG | 671 | Q8NDM7 | |
| WHLGLNCESASDHCH | 146 | P51690 | |
| LVAAAAFSGWCVHHV | 116 | Q07065 | |
| HCAHEAEEAGIWQHV | 811 | P33076 | |
| HHGHHTDVVREACWA | 231 | Q6NXE6 | |
| WSHECVVCFFAGHTH | 266 | Q3LIE5 | |
| QHRFWGFHDCTHQED | 326 | O43866 | |
| EHSGWGKHNCVHRED | 556 | Q9NR16 | |
| LHSFTAVCQDDGTWH | 351 | P00736 | |
| IGHHGERSLESFCHW | 296 | Q8TE56 | |
| HHNTTCEAAHFGLWR | 41 | Q06432 | |
| AWGVCNHAFHFHCIS | 71 | P62877 | |
| DSSLHLWEIVHHNGC | 96 | Q15334 | |
| LCFEVFEHLGTHGWE | 881 | Q6ZVH7 | |
| WFHGSCVGVEEHHAV | 61 | Q6ZMT4 | |
| HSHRDVCARHSWASD | 581 | Q8NG48 | |
| SATWKVLHCTGHIHV | 186 | Q16665 | |
| HSSGEFSLLHDHEAW | 1621 | Q3V6T2 | |
| TGLHCVWCHLEIHDD | 296 | P23743 | |
| DGTWHHDCILDEDHS | 176 | O60449 | |
| ALGQSWHPEHFVCTH | 166 | O60711 | |
| TCVSEQHEYHWHDGV | 796 | Q7L590 | |
| CGSFCQHRDWEKHHH | 576 | O75081 | |
| QFECETSEAHVHVHW | 816 | Q5VST9 | |
| TWHPEHFVCTHCQEE | 376 | P49023 | |
| KDLQHHCVIHDAWSG | 271 | P08887 | |
| HCVIHDAWSGLRHVV | 276 | P08887 | |
| RETFSCHWTDEVHHG | 61 | P10912 | |
| CHWTDEVHHGTKNLG | 66 | P10912 | |
| WEFTHHTCSLHFPHE | 176 | P32246 | |
| DECSHHAYLHDQFWS | 221 | Q9Y2V0 | |
| FNHEHCCWNSEHVTF | 166 | P51795 | |
| HHDLHSWHAESCYEK | 246 | P98153 | |
| HTIHATGHCHIDTAW | 251 | Q9NTJ4 | |
| SHCVDDNSWTLVEHH | 201 | Q13322 | |
| CGHDKHATLWDAVGH | 561 | O00423 | |
| LEWFDHHGHVCIVFE | 226 | Q9HAZ1 | |
| STSVHHVLIWIHCFT | 176 | Q6DWJ6 | |
| WLSHNCGHHEDAGVI | 686 | Q9UGM3 | |
| WLSHNCGHHEDAGVI | 1206 | Q9UGM3 | |
| DWAFGHSIISCHVEH | 281 | Q8N9I5 | |
| HCTHEAGVHSVGLTW | 406 | Q99567 | |
| LLSTTGHWHDFAHLE | 951 | Q6ZUA9 | |
| TTTTHFAELWGHLDH | 66 | Q9Y4L5 | |
| VAILCTHKHWDHSGG | 166 | Q8N490 | |
| SEWNYLHHHHDASCR | 721 | Q6T4R5 | |
| ELCCTLSWVSDHHHN | 491 | Q8IXR5 | |
| SFADSAWHCVAIVHV | 671 | Q6ZNJ1 | |
| WDFHPHHVHSEFESF | 51 | P17947 | |
| HRGWKAHICSHEEDA | 101 | A1L4H1 | |
| HSVAWHHEGKQFICS | 241 | Q5T5C0 | |
| HEHATVCCKDENGWH | 286 | Q9UPX8 | |
| AAGHAWLSLDTHCHL | 551 | Q9H2X0 | |
| PCHHITSHCTWVAAH | 86 | Q96NS8 | |
| CEAFGWHAIIVDGHS | 206 | P29401 | |
| HATFELGATWIHGSH | 71 | Q9NWM0 | |
| AHELGHVVGFWHEHT | 241 | Q9Y6L7 | |
| FLHHWDVTEAVFHSL | 726 | Q9NXF1 | |
| DHEQWTLVADFTHHA | 26 | Q9NWT1 | |
| CDKGFFHISELHIHW | 36 | Q8N3J9 | |
| ALGTHWHPEHFCCVS | 301 | O43294 | |
| HLTAFHWELFRCVHE | 431 | Q9UHV5 | |
| LHNATCHSGEASFVW | 126 | Q9H4I2 |